The NFL defended the Philadelphia Eagles' medical handling of quarterback Jalen Hurts on Tuesday, following his season-ending diagnosis of blood clots. According to a person with knowledge of the matter who spoke on condition of anonymity, the league is not disciplining the team. While the NFL Players Association (NFLPA) has called for a full investigation, NFL Chief Medical Officer Dr. Allen Sills stated the team's care was "conservative" and "patient-focused."
Hurts was placed on injured reserve after a blood clot in his left calf, initially diagnosed as superficial vein thrombosis, traveled to his lungs. The Eagles and Hurts' agent, Nicole Lynn, confirmed on Monday, October 19, 2026, that the quarterback has deep vein thrombosis and bilateral pulmonary embolisms. The injury was first reported to medical staff on October 8 after a practice, three days before Hurts played in a game against Jacksonville in London.
Dr. Sills stated that the league remained in contact with the Eagles and the Cleveland Clinic in London throughout the treatment process. NFL Executive Vice President Jeff Miller also addressed reports that Hurts had gone 30 hours without sleep before a game, stating that tracking data and staff reports indicated Hurts slept for approximately seven to eight hours. The union, however, stated that determining the facts is essential to ensuring players receive proper care and noted the league currently does not plan a formal review.
The scale of the impact is concentrated on the Philadelphia Eagles organization and the NFLPA's membership of approximately 2,000 players. For the athlete, this represents a loss of all playing time and related performance incentives for the rest of the year. For the team, it necessitates a change in their primary quarterback position, affecting their competitive standing in the league. The NFLPA’s demand for an investigation highlights a specific labor dispute over whether team medical staffs prioritize player health or game availability, a central issue in collective bargaining and player safety protocols.
If the NFLPA succeeds in securing a full investigation, it could lead to changes in league-wide medical protocols for traveling with vascular issues, such as flying to international games in London. Dr. Caron Rockman, a vascular surgeon not involved in the case, noted that while flying with superficial thrombosis is a "judgment call," the progression of the disease in Hurts has triggered this heightened scrutiny. What happens next depends on whether the league maintains its stance against a formal review; currently, Hurts remains on injured reserve with no specific date set for his return to physical activity.